This is one of the earliest therapeutic signals and reflects the drug's central and peripheral effects on hunger-regulating pathways
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L
Since the pancreas has abundant GAD, a direct immunological destruction occurs in the pancreas and the patients will have diabetes mellitus
The oral form Oral semaglutide is a daily tablet
Consult your doctor or pharmacist for advice specific to your medications.
Though both have proven to effectively treat diabetes with weight loss, clinical studies have shown that Tirzepatide produces better results in weight reduction compared to Semaglutide